-+ 0.00%
-+ 0.00%
-+ 0.00%

Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call

Barchart·10/09/2026 07:00:00
Listen to the news

Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2026 financial results on Wednesday, November 4th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, November 4th, at 9:00 a.m. ET.

Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.